Loss-Making LifeMD, Inc. (NASDAQ:LFMD) Expected To Breakeven In The Medium-Term
Loss-Making LifeMD, Inc. (NASDAQ:LFMD) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at LifeMD, Inc.'s (NASDAQ:LFMD) future prospects. LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company's loss has recently broadened since it announced a US$24m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$26m, moving it further away from breakeven. Many investors are wondering about the rate at which LifeMD will turn a profit, with the big question being "when will the company breakeven?" In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.
由於LifeMD公司的業務可能正在重要的歷程節點上,我們認爲我們應該更加仔細地審視其未來前景。LifeMD公司作爲一家直接面向患者的遠程醫療公司,在美國爲消費者和醫療保健專業人員提供醫療保健服務。自公司宣佈在整個財年中損失2400萬美元以來,其最近的12個月的虧損是2600萬美元,虧損額不斷擴大,遠離企業盈虧平衡點。許多投資者都在想知道LifeMD公司將在何時實現盈利,最大的問題就是“公司何時實現盈虧平衡?”本文中,我們將談論該公司增長的預期以及分析師們何時預計其實現盈利。
Consensus from 6 of the American Healthcare Services analysts is that LifeMD is on the verge of breakeven. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$3.8m in 2025. So, the company is predicted to breakeven just over a year from today. How fast will the company have to grow each year in order to reach the breakeven point by 2025? Working backwards from analyst estimates, it turns out that they expect the company to grow 126% year-on-year, on average, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.
6位美國醫療保健服務分析師的共識是,LifeMD公司即將實現盈虧平衡。他們預計該公司將在2024年最終虧損,然後在2025年實現380萬美元的淨利潤。因此,該公司預計將在一年多的時間內實現盈虧平衡。公司每年需要增長多快才能在2025年達到盈虧平衡點?從分析師的估計往回推算,他們預計該公司年均增長126%,這是相當樂觀的!如果這個速度被證明過於激進,公司可能會比分析師預測的時間更晚實現盈利。
![earnings-per-share-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240624/0-c5092989c63f223e93d7bbd1963fd0c2-0-6f0924e751e06521d780bfec8380f1ed.png/big)
Given this is a high-level overview, we won't go into details of LifeMD's upcoming projects, however, take into account that typically healthcare tech companies, depending on the stage of product development, have irregular periods of cash flow. This means that a high growth rate is not unusual, especially if the company is currently in an investment period.
鑑於這僅僅是一個概述,我們不會詳細介紹LifeMD公司即將推出的項目,但應考慮到通常情況下醫療技術公司會根據產品開發階段有不規則的現金流週期。這意味着高增長率並不罕見,特別是如果公司當前正處於投資期。
One thing we would like to bring into light with LifeMD is its debt-to-equity ratio of over 2x. Generally, the rule of thumb is debt shouldn't exceed 40% of your equity, which in this case, the company has significantly overshot. A higher level of debt requires more stringent capital management which increases the risk in investing in the loss-making company.
我們想要揭示的LifeMD的一件事是其超過2倍的負債股本比率。一般來說,負債不應超過股本的40%,而在這種情況下,該公司已經明顯超標。更高的債務水平需要更嚴格的資本管理,這增加了投資這家虧損公司的風險。
Next Steps:
下一步:
There are key fundamentals of LifeMD which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at LifeMD, take a look at LifeMD's company page on Simply Wall St. We've also compiled a list of essential aspects you should look at:
本文中未涵蓋到的LifeMD的關鍵基本面,其中我們必須再次強調,這僅僅是一個基本概述。如果您要更全面地了解LifeMD,請訪問Simply Wall St上LifeMD的公司頁面。我們還編制了一份必要的要素列表:
- Valuation: What is LifeMD worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether LifeMD is currently mispriced by the market.
- Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on LifeMD's board and the CEO's background.
- Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
- 估值:今天LifeMD公司值多少錢?未來的增長潛力已經被市場充分反映在價格中了嗎?我們的免費研究報告中的內在價值信息圖可以幫助您確定LifeMD公司當前是否被市場錯誤定價。
- 管理團隊:經驗豐富的管理團隊有助於增強我們對業務的信心-請查看LifeMD公司董事會成員和CEO的背景。
- 其他高表現的股票:是否有其他表現更好的股票並具有經過驗證的歷史記錄?查看這裏的免費列表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com